Unknown

Dataset Information

Cost burden and net monetary benefit loss of neonatal hypoglycaemia.


ABSTRACT:

Background

Neonatal hypoglycaemia is a common but treatable metabolic disorder that affects newborn infants and which, if not identified and treated adequately, may result in neurological sequelae that persist for the lifetime of the patient. The long-term financial and quality-of-life burden of neonatal hypoglycaemia has not been previously examined.

Methods

We assessed the postnatal hospital and long-term costs associated with neonatal hypoglycaemia over 80 year and 18 year time horizons, using a health-system perspective and assessing impact on quality of life using quality-adjusted life year (QALYs). A decision analytic model was used to represent key outcomes in the presence and absence of neonatal hypoglycaemia.

Results

The chance of developing one of the outcom

SUBMITTER: Glasgow MJ 

PROVIDER: S-EPMC7863541 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature